Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
Qualcomm
QCOM
$160B
| $87M | 0.1% |
1,298,600
+266,400
| +26% | +$17.5M |
|
152
CALL
DuPont de Nemours
DD
$18.7B
| $86.9M | 0.1% |
902,856
+717,420
| +387% | +$66.8M |
|
153
Occidental Petroleum
OXY
$55.6B
| $86.7M | 0.1% |
973,041
+138,305
| +17% | +$11.9M |
|
154
Gilead Sciences
GILD
$163B
| $86.6M | 0.1% |
1,397,206
+253,079
| +22% | +$15.1M |
|
155
CALL
Amazon
AMZN
$2.53T
| $86.5M | 0.1% |
5,547,600
-134,000
| -2% | -$2M |
|
156
CALL
iShares Biotechnology ETF
IBB
$9.52B
| $86.4M | 0.1% |
1,239,900
+1,184,100
| +2,122% | +$77.6M |
|
157
Public Storage
PSA
$59.3B
| $86.2M | 0.1% |
538,652
+277,873
| +107% | +$44M |
|
158
Booking.com
BKNG
$150B
| $85M | 0.1% |
2,102,850
+89,550
| +4% | +$3.35M |
|
|
159
PUT
Amazon
AMZN
$2.53T
| $84.6M | 0.1% |
5,425,800
-301,000
| -5% | -$4.49M |
|
160
UnitedHealth
UNH
$383B
| $84.5M | 0.1% |
1,190,052
-48,505
| -4% | -$3.47M |
|
161
MetLife
MET
$62.5B
| $84.3M | 0.1% |
2,055,440
+141,865
| +7% | +$6.11M |
|
|
EMC
162
DELISTED
EMC CORPORATION
EMC
| $84.1M | 0.1% |
3,365,253
+148,177
| +5% | +$3.85M |
|
163
Mondelez International
MDLZ
$80.5B
| $83.9M | 0.1% |
2,705,382
-93,682
| -3% | -$2.91M |
|
|
164
CALL
Occidental Petroleum
OXY
$55.6B
| $83.6M | 0.1% |
938,353
-1,114,647
| -54% | -$95.8M |
|
165
PUT
Biogen
BIIB
$30.7B
| $83.4M | 0.1% |
347,300
+66,800
| +24% | +$15M |
|
166
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| $83M | 0.1% |
4,977,043
+1,691,974
| +52% | +$30M |
|
|
167
CALL
Booking.com
BKNG
$150B
| $82.8M | 0.1% |
2,050,000
+72,500
| +4% | +$2.71M |
|
|
168
CALL
Gilead Sciences
GILD
$163B
| $82.7M | 0.1% |
1,334,100
-131,400
| -9% | -$7.85M |
|
169
CALL
JPMorgan Chase
JPM
$933B
| $82.7M | 0.1% |
1,621,500
+298,700
| +23% | +$16M |
|
170
PUT
Goldman Sachs
GS
$302B
| $82M | 0.1% |
519,000
-15,600
| -3% | -$2.51M |
|
171
Abbott
ABT
$183B
| $81.9M | 0.1% |
2,482,488
+709,539
| +40% | +$24.9M |
|
|
DD
172
DELISTED
Du Pont De Nemours E I
DD
| $81.1M | 0.1% |
1,472,956
+39,580
| +3% | +$2.16M |
|
173
eBay
EBAY
$50.4B
| $81.1M | 0.1% |
3,503,369
+414,153
| +13% | +$9.29M |
|
|
SWY
174
DELISTED
SAFEWAY INC
SWY
| $80.8M | 0.1% |
2,911,782
-1,158,367
| -28% | -$27.6M |
|
175
CVS Health
CVS
$134B
| $80.6M | 0.1% |
1,439,703
+293,402
| +26% | +$17.5M |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.